• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于多组代谢组学分析[具体药物名称缺失]在高尿酸血症治疗中的应用

Multi metabolomics-based analysis of application of in the treatment of hyperuricemia.

作者信息

Zhang Wenwen, Cui Yifang, Zhang Jiayu

机构信息

The School of Pharmacy, Binzhou Medical University, Yantai, China.

The School of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, China.

出版信息

Front Pharmacol. 2022 Jul 22;13:948939. doi: 10.3389/fphar.2022.948939. eCollection 2022.

DOI:10.3389/fphar.2022.948939
PMID:35935868
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9355468/
Abstract

Hyperuricemia (HUA) is a common metabolic disease that is an independent risk factor for comorbidities such as hypertension, chronic kidney disease, and coronary artery disease. The prevalence of HUA has increased over the last several decades with improved living standards and increased lifespans. Metabolites are considered the most direct reflection of individual physiological and pathological conditions, and represent attractive candidates to provide deep insights into disease phenotypes. Metabolomics, a technique used to profile metabolites in biofluids and tissues, is a powerful tool for identification of novel biomarkers, and can be used to provide valuable insights into the etiopathogenesis of metabolic diseases and to evaluate the efficacy of drugs. In this study, multi metabolomics-based analysis of the blood, urine, and feces of rats with HUA showed that HUA significantly altered metabolite profiles. (AM) and benbromomalone significantly mitigated these changes in blood and feces, but not in urine. Some crucial metabolic pathways including lipid metabolism, lipid signaling, hormones synthesis, unsaturated fatty acid (UFAs) absorption, and tryptophan metabolism, were seriously disrupted in HUA rats. In addition, AM administration exerted better treatment effects on HUA than benbromomalone. Furthermore, additional supplementation with UFAs and tryptophan may also induce therapeutic effects against HUA.

摘要

高尿酸血症(HUA)是一种常见的代谢性疾病,是高血压、慢性肾病和冠状动脉疾病等合并症的独立危险因素。在过去几十年中,随着生活水平的提高和寿命的延长,HUA的患病率有所上升。代谢物被认为是个体生理和病理状况的最直接反映,是深入了解疾病表型的有吸引力的候选物。代谢组学是一种用于分析生物流体和组织中代谢物的技术,是鉴定新型生物标志物的强大工具,可用于深入了解代谢性疾病的病因发病机制并评估药物疗效。在本研究中,基于多代谢组学对HUA大鼠的血液、尿液和粪便进行分析,结果表明HUA显著改变了代谢物谱。氨基蝶呤(AM)和苯溴马隆显著减轻了血液和粪便中的这些变化,但对尿液中的变化没有影响。一些关键的代谢途径,包括脂质代谢、脂质信号传导、激素合成、不饱和脂肪酸(UFA)吸收和色氨酸代谢,在HUA大鼠中受到严重破坏。此外,AM给药对HUA的治疗效果优于苯溴马隆。此外,额外补充UFA和色氨酸也可能对HUA产生治疗作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6197/9355468/e0e84e37a67b/fphar-13-948939-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6197/9355468/fc0548f1b640/fphar-13-948939-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6197/9355468/a8ba9a994617/fphar-13-948939-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6197/9355468/4471405fa8cd/fphar-13-948939-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6197/9355468/7bdde0290448/fphar-13-948939-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6197/9355468/e0e84e37a67b/fphar-13-948939-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6197/9355468/fc0548f1b640/fphar-13-948939-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6197/9355468/a8ba9a994617/fphar-13-948939-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6197/9355468/4471405fa8cd/fphar-13-948939-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6197/9355468/7bdde0290448/fphar-13-948939-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6197/9355468/e0e84e37a67b/fphar-13-948939-g005.jpg

相似文献

1
Multi metabolomics-based analysis of application of in the treatment of hyperuricemia.基于多组代谢组学分析[具体药物名称缺失]在高尿酸血症治疗中的应用
Front Pharmacol. 2022 Jul 22;13:948939. doi: 10.3389/fphar.2022.948939. eCollection 2022.
2
Metabolic pathway analysis of hyperuricaemia patients with hyperlipidaemia based on high-throughput mass spectrometry: a case‒control study.基于高通量质谱的高尿酸血症合并高脂血症患者代谢通路分析:病例对照研究。
Lipids Health Dis. 2022 Dec 31;21(1):151. doi: 10.1186/s12944-022-01765-0.
3
High-Throughput Untargeted Serum Metabolomics Analysis of Hyperuricemia Patients by UPLC-Q-TOF/MS.基于超高效液相色谱-四极杆飞行时间质谱联用技术的高尿酸血症患者血清非靶向代谢组学高通量分析
Evid Based Complement Alternat Med. 2021 Jun 12;2021:5524772. doi: 10.1155/2021/5524772. eCollection 2021.
4
NMR spectroscopy based metabolomics confirms the aggravation of metabolic disorder in metabolic syndrome combined with hyperuricemia.基于核磁共振光谱的代谢组学证实,代谢综合征合并高尿酸血症会加重代谢紊乱。
Nutr Metab Cardiovasc Dis. 2021 Jul 22;31(8):2449-2457. doi: 10.1016/j.numecd.2021.05.015. Epub 2021 May 24.
5
Metabolomics approach by H NMR spectroscopy of serum reveals progression axes for asymptomatic hyperuricemia and gout.基于血清~1H-NMR 代谢组学的研究揭示无症状高尿酸血症和痛风的进展轴。
Arthritis Res Ther. 2018 Jun 5;20(1):111. doi: 10.1186/s13075-018-1600-5.
6
Biomarker identification and pathway analysis of and couplet medicines on adenine-induced chronic kidney disease in rats based on metabolomics.基于代谢组学的对药对腺嘌呤诱导的大鼠慢性肾脏病的生物标志物鉴定及通路分析
Front Pharmacol. 2023 Apr 6;14:1103527. doi: 10.3389/fphar.2023.1103527. eCollection 2023.
7
Kidney and plasma metabolomics provide insights into the molecular mechanisms of urate nephropathy in a mouse model of hyperuricemia.肾和血浆代谢组学为高尿酸血症小鼠模型尿酸肾病的分子机制提供了新见解。
Biochim Biophys Acta Mol Basis Dis. 2022 Jun 1;1868(6):166374. doi: 10.1016/j.bbadis.2022.166374. Epub 2022 Mar 9.
8
Analysis of non-targeted serum metabolomics in patients with chronic kidney disease and hyperuricemia.慢性肾脏病合并高尿酸血症患者的非靶向血清代谢组学分析。
Biotechnol Genet Eng Rev. 2024 Dec;40(4):4013-4039. doi: 10.1080/02648725.2023.2204715. Epub 2023 Apr 26.
9
Altered metabolic profiles and biomarkers associated with astragaloside IV-mediated protection against cisplatin-induced acute kidney injury in rats: An HPLC-TOF/MS-based untargeted metabolomics study.基于 HPLC-TOF/MS 的非靶向代谢组学研究:黄芪甲苷介导的防治顺铂诱导的大鼠急性肾损伤的代谢谱和生物标志物的变化。
Biochem Pharmacol. 2021 Jan;183:114299. doi: 10.1016/j.bcp.2020.114299. Epub 2020 Oct 24.
10
Investigation of pathogenesis of hyperuricemia based on untargeted and targeted metabolomics.基于非靶向和靶向代谢组学研究高尿酸血症的发病机制。
Sci Rep. 2022 Aug 17;12(1):13980. doi: 10.1038/s41598-022-18361-y.

引用本文的文献

1
Drug repurposing in traditional Chinese medicine: from empirical wisdom to modern therapeutic strategies.中药中的药物重新利用:从经验智慧到现代治疗策略。
Front Pharmacol. 2025 Jul 31;16:1631727. doi: 10.3389/fphar.2025.1631727. eCollection 2025.
2
Research progress on the mechanism of hyperuricemic nephropathy based on multi-omics technique: A review.基于多组学技术的高尿酸血症肾病发病机制研究进展:综述
Medicine (Baltimore). 2024 Dec 20;103(51):e40975. doi: 10.1097/MD.0000000000040975.
3
Untargeted and Targeted Metabolomics Reveal the Active Peptide of Walker against Hyperlipidemia by Modulating Imbalance in Amino Acid Metabolism.

本文引用的文献

1
Protein -Mannosylation and -Mannosyl Tryptophan in Chemical Biology and Medicine.蛋白质的甘露糖化和色氨酸的甘露糖化在化学生物学和医学中的应用。
Molecules. 2021 Aug 30;26(17):5258. doi: 10.3390/molecules26175258.
2
UPLC-MS/MS Method for Analysis of Endocannabinoid and Related Lipid Metabolism in Mouse Mucosal Tissue.用于分析小鼠黏膜组织中内源性大麻素及相关脂质代谢的超高效液相色谱-串联质谱法
Front Physiol. 2021 Jul 14;12:699712. doi: 10.3389/fphys.2021.699712. eCollection 2021.
3
Obesity interacts with hyperuricemia on the severity of non-alcoholic fatty liver disease.
非靶向和靶向代谢组学揭示 Walker 肽通过调节氨基酸代谢失衡发挥抗高血脂作用。
Molecules. 2023 Oct 12;28(20):7049. doi: 10.3390/molecules28207049.
4
16S rRNA and Metagenomics Combined with UPLC-Q/TOF-MS Metabolomics Analysis Reveals the Potential Mechanism of Radix Astragali Against Hyperuricemia in Mice.16S rRNA 和宏基因组学联合 UPLC-Q/TOF-MS 代谢组学分析揭示黄芪抗小鼠高尿酸血症的潜在机制。
Drug Des Devel Ther. 2023 May 6;17:1371-1386. doi: 10.2147/DDDT.S407983. eCollection 2023.
5
The Therapeutic Effect and the Potential Mechanism of Flavonoids and Phenolics of Lam. Leaves against Hyperuricemia Mice.柳叶菜科植物的黄酮类和酚类化合物对高尿酸血症小鼠的治疗作用及潜在机制。
Molecules. 2022 Nov 25;27(23):8237. doi: 10.3390/molecules27238237.
肥胖症与高尿酸血症相互作用会加重非酒精性脂肪性肝病的严重程度。
BMC Gastroenterol. 2021 Jan 28;21(1):43. doi: 10.1186/s12876-021-01615-w.
4
Association of Hyperuricemia With Acute Kidney Injury: Case Series Report Among Patients Hospitalized With General Tonic-Clonic Seizures.高尿酸血症与急性肾损伤的关联:全身性强直阵挛性发作住院患者的病例系列报告
Can J Kidney Health Dis. 2020 Dec 8;7:2054358120977386. doi: 10.1177/2054358120977386. eCollection 2020.
5
[Asymptomatic Hyperuricemia and Risk Of Cardiovascular and Renal Diseases].无症状高尿酸血症与心血管及肾脏疾病风险
Kardiologiia. 2020 Nov 12;60(10):113-121. doi: 10.18087/cardio.2020.10.n1153.
6
Profiling of polar urine metabolite extracts from Chinese colorectal cancer patients to screen for potential diagnostic and adverse-effect biomarkers.对中国结直肠癌患者的极性尿液代谢物提取物进行分析,以筛选潜在的诊断和不良反应生物标志物。
J Cancer. 2020 Oct 8;11(23):6925-6938. doi: 10.7150/jca.47631. eCollection 2020.
7
Monomeric C-mannosyl tryptophan is a degradation product of autophagy in cultured cells.单体 C-甘露糖基色氨酸是培养细胞自噬的降解产物。
Glycoconj J. 2020 Oct;37(5):635-645. doi: 10.1007/s10719-020-09938-8. Epub 2020 Aug 17.
8
Research Advances in the Mechanisms of Hyperuricemia-Induced Renal Injury.高尿酸血症致肾损伤机制的研究进展。
Biomed Res Int. 2020 Jun 26;2020:5817348. doi: 10.1155/2020/5817348. eCollection 2020.
9
A novel eicosapentaenoic acid-derived anti-inflammatory lipid mediator 5,6-DiHETE is abundant in blue back fish intestines.一种新型的二十碳五烯酸衍生的抗炎脂质介质 5,6-DiHETE 在蓝鳕鱼肠中含量丰富。
J Food Sci. 2020 Jul;85(7):1983-1987. doi: 10.1111/1750-3841.15179. Epub 2020 Jun 22.
10
Effects and Mechanisms of Six Nostrum for Treatment of Hyperuricemia with Hyperlipidemia.六种验方治疗高尿酸血症伴高脂血症的疗效及机制
Evid Based Complement Alternat Med. 2020 Mar 30;2020:2914019. doi: 10.1155/2020/2914019. eCollection 2020.